Session Chair: Dr. Colin Collins, Professor, UCSF Cancer Center, USA Co-Chair: Dr. Jun-Ping Liu, Professor of Monash University, Australia

Title: Targeting Gene-Virotherapy of Cancer
Dr. Xinyuan Liu, Professor, member of CAS, China

Title: A New Paradigm in New Drug Development from CMC Preclinical Study to Clinic Evaluation: The Emerging Roles of China in Global Drug Development
Dr. Yu L. Huang, CTO, Bio-Cancer Treatment International Limited, China

Title: Chemistry and Biology of Chromatin Remodeling Agents
Dr. Manuela Rodriquez, Visiting Scientist, Broad Institute of Harvard and MIT, USA

Title: RhoC and Metastasis in Liver Cancer
Dr. Mary Waye, Professor, Department of Biochemistry, The Chinese University of Hong Kong, China

Title: Targeting Acid Ceramidase: A New Strategy To Enhance Combination Therapy of Cancer
Dr. James S. Norris, Professor and Chairman, Department of Microbiology & Immunology at the Medical University of South Carolina, USA

Title: Targeting Delivery of Cytokines to Tumor Neovasculature
Dr. Angelo Corti, Professor of Biochemistry, Department of Oncology, San Raffaele Scientific Institute, Italy

Title: Molecular Mechanism of RecQ Helicases Function in Human Cancers and Premature Aging Syndromes
Dr. Jin-Shan Hu, associate professor, Department of Basic Medical Sciences, COMP, Western University of Health Sciences, USA